No Data
No Data
Maxim Group Initiates Biorestorative Therapies(BRTX.US) With Buy Rating, Announces Target Price $8
Promising Phase 2 Results and Market Dynamics Boost Confidence in BioRestorative Therapies
BioRestorative Therapies Issues Regulation FD Disclosure
BioRestorative Therapies Announces New Data on BRTX-100 Presented at ORS 2025
Express News | BioRestorative Therapies, Inc. Highlights Presentation Or Preliminary BRTX-100 Data At Orthopaedic Research Society
BRTX-100 Front and Center at ORS 2025
Unlock the Full List